/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Dendreon Corp.\n \n\n\n\n\n
Nov 21 2:29 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 20, 2009 8:30 AM EST
\n\n \n Dendreon Receives FDA Acknowledgement of Complete Response - PR Newswire\n \n \n
\n\n Nov 12, 2009 6:45 AM EST
\n\n \n Unbiased Analysis on FITB, HCBK, ADSK, HBAN, FINL and DNDN Posted on WallStSense.com - Marketwire\n \n \n
\n\n Nov 11, 2009 4:00 PM EST
\n\n \n Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization - PR Newswire\n \n \n
\n\n Nov 03, 2009 6:14 AM EST
\n\n \n BenchmarkJournal.com Issues Independent Review on FINL, FSLR, EWBC, FITB, BARE and DNDN - Marketwire\n \n \n
\n\n Nov 02, 2009 8:31 AM EST
\n\n \n Dendreon Completes Submission of Biologics License Application for PROVENGE - PR Newswire\n \n \n
\n\n Oct 30, 2009 7:30 AM EDT
\n\n \n Dendreon to Hold Conference Call on Wednesday, November 11, 2009 at 4:30 PM ET - PR Newswire\n \n \n
\n\n Oct 29, 2009 7:30 AM EDT
\n\n \n Dendreon Announces Webcast Presentations at Upcoming Investor Conferences - PR Newswire\n \n \n
\n
\n\n");